Keywords: teva/aventis, launch, pre-filled, copaxine, syringe, europe, israel
Teva/Aventis launch pre-filled Copaxine syringe in Europe
Article | 28 June 2004
Israel's Teva Pharmaceutical Industries and Franco-German drugmaker Aventis have introduced Copaxone (glatiramer acetate injection) as a pre-filled ready-to-use syringe in ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- New study shows UCB's Neupro reduces NSBP in RLS patient
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
